Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 25Colorectal Neoplasms 21Lung Neoplasms 12Neoplasms 7Pancreatic Neoplasms 6Ovarian Neoplasms 6Head and Neck Neoplasms 6Colonic Neoplasms 6Stomach Neoplasms 5Esophageal Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Small Cell Lung Carcinoma 4Rectal Neoplasms 4Neoplasm Metastasis 4Triple Negative Breast Neoplasms 3Peritoneal Neoplasms 3Mesothelioma 3Melanoma 3Carcinoma, Pancreatic Ductal 3Breast Neoplasms 3Urinary Bladder Neoplasms 2Thyroid Neoplasms 2Kidney Neoplasms 2Fallopian Tube Neoplasms 2Carcinoma, Renal Cell 2Biliary Tract Neoplasms 2Vipoma 1Uterine Cervical Neoplasms 1Tracheal Neoplasms 1Spinocerebellar Degenerations 1

Interventions

Interferons 1Fluorouracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastrointestinal Cancer Metastatic × Fluorouracil × Thoracic × Clear all
NCT01658813 2018-03-21

5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung Cancer

Western Regional Medical Center

Phase 2 Completed
18 enrolled 2 charts
GastrointestinalGenitourinaryThoracic

Gastrointestinal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡